Literature DB >> 9488281

Initial treatment for open-angle glaucoma- medical, laser, or surgical? Surgery is the treatment of choice for open-angle glaucoma.

R Hitchings1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9488281     DOI： 10.1001/archopht.116.2.241

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  11 in total

1.  Effect of Trabeculectomy on OCT Measurements of the Optic Nerve Head Neuroretinal Rim Tissue.

Authors:  Facundo G Sanchez; David S Sanders; Jessica J Moon; Stuart K Gardiner; Juan Reynaud; Brad Fortune; Steven L Mansberger
Journal:  Ophthalmol Glaucoma       Date:  2019-10-04

2.  Effects of bevacizumab loaded PEG-PCL-PEG hydrogel intracameral application on intraocular pressure after glaucoma filtration surgery.

Authors:  Qian Han; Yuqi Wang; Xiabin Li; Ribo Peng; Ailing Li; Zhiyong Qian; Ling Yu
Journal:  J Mater Sci Mater Med       Date:  2015-08-19       Impact factor: 3.896

Review 3.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

4.  Difference in Outcomes between First-Operated vs. Fellow-Operated Eyes in Patients Undergoing Bilateral Trabeculectomies.

Authors:  Younhea Jung; Hae-Young L Park; Na Young Lee; Young-Sik Yoo; Chan Kee Park
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

5.  Inhibition of placental growth factor improves surgical outcome of glaucoma surgery.

Authors:  Tine Van Bergen; Bart Jonckx; Karolien Hollanders; Davine Sijnave; Sarah Van de Velde; Evelien Vandewalle; Lieve Moons; Jean-Marie Stassen; Ingeborg Stalmans
Journal:  J Cell Mol Med       Date:  2013-10-09       Impact factor: 5.310

6.  Anti-VEGF agents with or without antimetabolites in trabeculectomy for glaucoma: a meta-analysis.

Authors:  Qi Xiong; Zhiliang Li; Zhaohui Li; Yi Zhu; Sancar Abdulhalim; Ping Wang; Xiaojun Cai
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

Review 7.  Improving patient outcomes following glaucoma surgery: state of the art and future perspectives.

Authors:  Tine Van Bergen; Sarah Van de Velde; Evelien Vandewalle; Lieve Moons; Ingeborg Stalmans
Journal:  Clin Ophthalmol       Date:  2014-05-02

8.  Comparing Trabeculectomy Outcomes between First and Second Operated Eyes: A Multicenter Study.

Authors:  Kentaro Iwasaki; Yoshihiro Takamura; Takashi Nishida; Akira Sawada; Keiichiro Iwao; Ayano Shinmura; Shiho Kunimatsu-Sanuki; Tetsuya Yamamoto; Hidenobu Tanihara; Kazuhisa Sugiyama; Toru Nakazawa; Masaru Inatani
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

9.  First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery.

Authors:  Norbert Pfeiffer; Bogomil Voykov; Giulia Renieri; Katharina Bell; Paul Richter; Melanie Weigel; Hagen Thieme; Barbara Wilhelm; Katrin Lorenz; Martin Feindor; Katja Wosikowski; Michel Janicot; Daniela Päckert; Regina Römmich; Carola Mala; Petra Fettes; Eugen Leo
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery.

Authors:  Lei Zuo; Jianhong Zhang; Xun Xu
Journal:  J Ophthalmol       Date:  2018-09-09       Impact factor: 1.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.